About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials | 1,265 Studies Recruiting

Clinical TrialsLupus

Lupus Clinical Trials

Browse 1,265 clinical trials for lupus. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1181-1200 of 1,265 trials

CompletedFLARE Lupus Research Study Systemic Lupus ErythematosusThe first phase of this pilot study will assess changes in quality of life at the end of a 16-week Mymee program in patients with moderate to severe SLE.NCT03426384·New York, New York Not yet recruitingEstablishing the Salience of Type 1 Interferon Pathway Blockade in the Central Mechanisms of SLE Related FatigueSystemic Lupus Erythematosus (SLE) is a multi-system autoimmune disorder, characterised by activation of the interferon system.NCT06784076 UnknownAn Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus ErythematosusThis is a monocenter, open-label Phase II trial for refractory SLE patients currently on stable background immunosuppressive therapy.NCT04810754 TerminatedA Study of Ustekinumab in Participants With Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the efficacy of ustekinumab in participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or…NCT03517722·Anniston, Alabama and 203 others

Related Searches

sletrials systemic lupustrials

Data from ClinicalTrials.govTerms

CompletedSubcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus ErythematosusThe objective of this study is to evaluate and compare efficacy of 3 dose levels of PF-04236921 to placebo in subjects with generalized lupus using a measure called the Systemic…NCT01405196·Anniston, Alabama and 112 others

TerminatedSafety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's SyndromeThis is a Phase I-II open- label single-dose study in subjects with significant refractory Rheumatoid Arthritis (RA), relapsing Systemic Lupus Erythematosus (SLE) or Sharp's…NCT02741362·Little Rock, Arkansas

UnknownNew Signaling Pathway Targeting Systemic Lupus ErythematosusSystemic lupus erythematosus is inflammatory autoimmune disease that affects over one million people in the United States.NCT03984227

CompletedAn Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE)This trial is conducted in North America.NCT00960362·Birmingham, Alabama and 5 others

Not yet recruitingFibroblast Growth Factor 21 in Systemic Lupus ErythematosusSystemic lupus erythematosus (SLE) is a chronic disorder characterized by profound immune and metabolic disturbances.NCT06842810

CompletedSearching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic TechniquesObjective: To search for potential biomarkers obtained by non-invasive methods (24-hour urine collection) that distinguish between patients diagnosed with systemic lupus…NCT03687138·Bilbao, Bizkaia

Not yet recruitingRD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune DiseasesThis is a single-arm, open-label, phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of RD06-05, a universal CD19/BCMA…NCT07674147·Nanjing, Jiangsu and 1 other

CompletedA Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusPrimary objective: To assess the efficacy and safety of different dose regimens of ALX-0061 administered subcutaneously (s.c.) to subjects with moderate to severe active…NCT02437890·Birmingham, Alabama and 117 others

UnknownClinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus ErythematosusSystemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by production of autoantibodies directed against nuclear and cytoplasmic antigens.NCT05179018

RecruitingAnifrolumab Malignancy and Serious Infections StudyThis is an observational study, in which the main research question is to evaluate the risk of malignancies and serious infections among moderate/severe SLE patients who receive…NCT07000110·Copenhagen and 3 others

UnknownOsteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial)The trial is designed to evaluate prevalence of fragility fracture, their impact on quality of life of SLE patients and disease or treatment variables such as steroids dosage or…NCT05590390·Verona

CompletedWeb-based Genetic Research on LupusThe goal of this new lupus research study is two-fold: first, to understand the genetic associations found between people's DNA and this disease, and second, to apply this…NCT02530944·Mountain View, California

CompletedA Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVEThe purpose of this study is to assess whether co-administration of belimumab and a single cycle of rituximab will optimize treatment with belimumab, which will result in…NCT03312907·Birmingham, Alabama and 78 others

CompletedImmunogenicity and Safety of HPV Vaccine Gardasil in Young WomenThe purpose of this study is to evaluate the immunogenicity and safety of the HPV vaccine Gardasil in young women.NCT00786409·Chicago, Illinois

TerminatedCOVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic DiseasesThe trial is a prospective, observational study aiming to identify risk factors for serious COVID-19 infection by evaluating clinical measures and biomarkers of inflammation in…NCT04335747·Aalborg

RecruitingAn Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsA Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus…NCT05835310·Phoenix, Arizona and 102 others

PreviousPage 60 of 64Next